+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Clopidogrel-Induced Insulin Autoimmune Syndrome: A Newly Recognized Cause of Hypoglycemia in a Patient Without Diabetes



Clopidogrel-Induced Insulin Autoimmune Syndrome: A Newly Recognized Cause of Hypoglycemia in a Patient Without Diabetes



Journal of the Endocrine Society 1(9): 1217-1223



Insulin autoimmune syndrome (IAS), defined as hyperinsulinemic hypoglycemia with high titers of anti-insulin antibodies, is frequently reported in Japanese patients but rarely observed in whites. We report in this study on a 79-year-old white male without diabetes who developed IAS following exposure to clopidogrel, a drug not previously known to cause hypoglycemia. The patient presented with recurrent symptomatic hypoglycemia. During one episode, serum glucose was 45 mg/dL, whereas insulin and C-peptide levels were 40,000 mIU/mL and 40 ng/mL, respectively. Additional studies revealed no intake of insulin or its secretagogues, whereas anti-insulin antibody titer was high (59.3 nmol/L). Although total insulin levels were consistently high, free insulin concentrations (polyethylene glycol precipitation) were appropriate for ambient glycemia. The patient was found to have HLA-DRB1*0404, a feature often reported in Japanese patients with IAS. Three weeks prior to symptom onset, he was started on clopidogrel, a drug that does not have a sulfhydryl group, but its active metabolite does. Clopidogrel was switched to a nonsulfhydryl antiplatelet agent, and glucocorticoid therapy was initiated. Shortly thereafter, the frequency of hypoglycemic episodes decreased, and glucocorticoids were tapered over the ensuing 3 months. No hypoglycemic episodes were noted during 6 months of observation after discontinuing glucocorticoids, whereas the total insulin and anti-insulin antibody levels normalized. The data indicate that IAS should be considered in the differential diagnosis of hyperinsulinemic hypoglycemia in seemingly well individuals, even when no drugs known to cause IAS were used. Clinical suspicion of IAS can avoid expensive imaging and unnecessary surgery in affected patients.

(PDF emailed within 0-6 h: $19.90)

Accession: 055115573

Download citation: RISBibTeXText

PMID: 29264578

DOI: 10.1210/js.2017-00316


Related references

Hypoglycemia and transient diabetes mellitus in an insulin autoimmune syndrome. Deutsche Medizinische Wochenschrift 129(20): 1135-1138, 2004

Hypoglycemia and transitory diabetes mellitus in an insulin autoimmune syndrome. DMW Deutsche Medizinische Wochenschrift 129(20): 1135-1138, May 14, 2004

Late postprandial hypoglycemia due to bioactive insulin dissociation from autoantibody leading to unconsciousness in a patient with insulin autoimmune syndrome. Internal Medicine 50(4): 339-343, 2011

Mechanism of hypoglycemia observed in a patient with insulin autoimmune syndrome. Diabetes 26(5): 500-506, 1977

A type 1 diabetic patient with prolonged fasting hypoglycemia and postprandial hyperglycemia due to insulin autoimmune syndrome like insulin antibodies: Evaluation by Scatchard analysis. Journal of the Japan Diabetes Society 45(7): 471-476, 2002

Patient characteristics, drug adherence patterns, and hypoglycemia costs for patients with type 2 diabetes mellitus newly initiated on exenatide or insulin glargine. Current Medical Research and Opinion 25(3): 777-786, 2010

Severe hypoglycemia secondary to methimazole-induced insulin autoimmune syndrome in a 16 year old African-American male. Pediatric Diabetes 13(8): 652-655, 2013

Analytical and clinical challenges in a patient with concurrent type 1 diabetes, subcutaneous insulin resistance and insulin autoimmune syndrome. Endocrinology, Diabetes & Metabolism Case Reports 2014(): 130086-130086, 2014

Characterization of insulin antibodies in autoimmune hypoglycemia and insulin treated diabetes mellitus. Journal of the Japan Diabetes Society 29(4): 319-329, 1986

Prolonged fasting hypoglycemia due to insulin antibodies in patient with non-insulin-dependent diabetes mellitus: effect of insulin withdrawal on insulin-antibody-binding kinetics. Diabetes Care 10(2): 160-163, 1987

Autoimmune hypoglycemia in a type 2 diabetic patient with anti-insulin and insulin receptor antibodies. Diabetes Care 27(1): 288-289, 2003

Autoimmune Hypoglycemia in a Type 2 Diabetic Patient With Anti-Insulin and Insulin Receptor Antibodies. Diabetes Care 27(1): 288-289, 2004

Insulin autoimmune syndrome during the administration of clopidogrel. Journal of Diabetes 8(4): 588-589, 2016

Estimation of glucose utilization in a type 2 diabetes mellitus patient on insulin analogs with tumor hypoglycemia induced by IGF-II. Growth Hormone & Igf Research 26: 8-10, 2016

Severe hypoglycemia due to insulin autoimmune syndrome with insulin autoantibodies crossreactive to proinsulin. Experimental and Clinical Endocrinology & Diabetes 109(4): 245-248, 2001